Canada - English - Health Canada

marcan pharmaceuticals inc - diltiazem hydrochloride - capsule (extended release) - 300mg - diltiazem hydrochloride 300mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

marcan pharmaceuticals inc - diltiazem hydrochloride - capsule (extended release) - 360mg - diltiazem hydrochloride 360mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

pro doc limitee - diltiazem hydrochloride - capsule (controlled-delivery) - 120mg - diltiazem hydrochloride 120mg

Canada - English - Health Canada

pro doc limitee - diltiazem hydrochloride - capsule (controlled-delivery) - 180mg - diltiazem hydrochloride 180mg

Canada - English - Health Canada

pro doc limitee - diltiazem hydrochloride - capsule (controlled-delivery) - 240mg - diltiazem hydrochloride 240mg

Canada - English - Health Canada

pro doc limitee - diltiazem hydrochloride - capsule (controlled-delivery) - 300mg - diltiazem hydrochloride 300mg

United States - English - NLM (National Library of Medicine)

apotex corp. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the treatment of hypertension. diltiazem hydrochloride may be used alone or in combination with other antihypertensive medications, such as diuretics. dilt-xr [diltiazem hydrochloride extended-release capsules, usp (once-a-day dosage)] are indicated for the management of chronic stable angina. diltiazem hydrochloride is contraindicated in: (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker; (2) patients with second or third degree av block except in the presence of a functioning ventricular pacemaker; (3) patients with hypotension (less than 90 mmhg systolic); (4) patients who have demonstrated hypersensitivity to the drug; and (5) patients with acute myocardial infarction and pulmonary congestion as documented by x-ray on admission.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medications. diltiazem hydrochloride extended-release capsules (once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker, (3) patients with hypotension (less than 90 mm hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.